Front Page Reviews Abstracts Guidelines Trustees Members Contact Us

EPUAP Logo  

EUROPEAN PRESSURE ULCER ADVISORY PANEL

Pressure Ulcer Prevalence Monitoring Project

SUMMARY REPORT ON THE PREVALENCE OF PRESSURE ULCERS

Data collected in Belgium, Italy, Portugal and the United Kingdom over 14-15 November 2001,
and in Sweden on 5 February 2002. This data forms part of the European Pressure Ulcer Advisory Panel's
pilot European hospitals' pressure ulcer prevalence monitoring project.
Michael Clark, Gerrie Bours and Tom de Flour, on behalf of the EPUAP Prevalence Working Group.

Early in 2000 the EPUAP committed to developing a minimum data set for use within pressure ulcer prevalence surveys. Over many months this set emerged from a series of intense meetings with the evolution of the minimum data set described in past EPUAP Reviews. Finally in 2001 the project collected data upon the condition of the skin of approximately 5000 hospital patients located in Belgium, Italy, Portugal and the United Kingdom. Early in 2002 further data was collected in Sweden. The first presentation of this important new data set was made in Budapest in September 2002 and the EPUAP is pleased to provide a summary of the data collected across the five counties that participated in the pilot project in this issue of the EPUAP Review.



Summary report on pressure ulcer prevalence

This data was collected in Belgium, Italy, Portugal and the United Kingdom over 14-15 November 2001, and in Sweden on 5 February 2002. It forms part of the European Pressure Ulcer Advisory Panel's pilot European hospitals' pressure ulcer prevalence monitoring project.

The data contained in this report is not to be disseminated or published in whatever format without the prior permission of the European Pressure Ulcer Advisory Panel.


Summary

The European Pressure Ulcer Advisory Panel (EPUAP) has conducted a pilot survey of the prevalence of pressure ulcers across a range of hospitals located within five European countries (Belgium, Italy, Portugal, Sweden and the United Kingdom). This report describes the data gathered across all of these countries. A total of 5947 patients were surveyed over 14-15 November 2001 (and on 5 February 2002 when all Swedish data was obtained), and of these 1078 (18.1%) had pressure ulcers. The prevalence of pressure ulcers within each country ranged from 8.3% (Italy) to 22.9% (Sweden).

The anatomical locations most commonly affected by pressure ulcers were the sacrum (in Italy and the UK) and the heels (Belgium, Portugal and Sweden). Of the 1078 patients with a pressure ulcer(s) the greatest number (n = 454, 42.1%) experienced non-blanching erythema as their most severe form of pressure damage. However, 143 patients experienced the most severe form of pressure damage (Grade 4 wounds).

The proportion of surveyed patients who received no pressure ulcer preventive interventions ranged from 10.4% (UK) to 92.1% (Italy), with relatively few patients receiving interventions deemed to be fully appropriate (n = 265, 4.6%). It should be noted that the pilot study did not recruit a representative sample of hospital sites and so the data presented within this report can not be considered to represent the 'true' picture of the prevalence and characteristics of pressure ulcers across acute care in Europe.


Background

One of the most common measures of the occurrence of pressure ulcers has been their prevalence, defined as the number of people with a pressure ulcer as a proportion of the entire patient population over a defined period of time. Pressure ulcer prevalence has been reported over the years across many countries and many health care providers. This measure provides information upon the current numbers of patients with pressure ulcers and the characteristics of their wounds. Measures of prevalence are not however suitable for identifying improvements in pressure ulcer occurrence following changes in practice given that prevalence includes patients admitted to a hospital with established pressure ulcers.

Comparison between these myriad prevalence proportions has been limited by various issues related to the performance of each survey - among the many confounding issues are;

  • Which patient groups have been surveyed; have areas such as maternity where pressure ulcers may be rare been included or excluded?
  • How have pressure ulcers been defined; did the survey count areas of non-reactive erythema as a pressure ulcer or were only frank skin breaks counted?
  • How was the data collected? Was the skin of all patients examined or were the results based on information passed by clinical staff?
These and many other factors effectively preclude any comparison between hospitals, regions and countries. For this reason the European Pressure Ulcer Advisory Panel (EPUAP) instigated a working group in 2000 to develop and test a methodology which would allow such comparisons to be made. The members of this working group are listed in Appendix 1. Heavily influenced by the work of the research team responsible for the annual Dutch national pressure ulcer survey, the EPUAP working group developed a data collection instrument (shown in Appendix 2) and piloted this instrument across five European countries (Belgium, Italy, Portugal, Sweden and the United Kingdom) over 14-15 November 2001 (and 5 February 2002 when Swedish data was collected). This report provides an overview of the data collected within these five European countries during the pilot survey.


Survey methodology

In each country a National Co-ordinator (NC) was appointed from among the ranks of the EPUAP Trustees and their colleagues. The primary roles of the NC were to identify potential hospitals in which data on the prevalence of pressure ulcers would be collected, and to facilitate staff within these hospitals to undertake the survey. The goals of the pilot survey were: a) to collect data from approximately 1000 hos-pital patients within each country and, b) to explore issues related to the implementation of a system for collecting prevalence data that could be used in different countries.

Having identified potential hospitals within each country, Research Ethics applications covering the performance of the survey were submitted (where each country's regulations required this to be done) and approval for data collection obtained. Over the period 14-15 November 2001 (and 5 February 2002 in Sweden) the skin of all in-patients staying overnight on the day of the survey was inspected by two nurses; one drawn from the clinical area's staff while the second formed part of the research team within each participating hospital.

During the survey information was collected upon the presence, anatomical location and severity of pressure ulcers. Each pressure ulcer's severity was assessed using the EPUAP pressure ulcer classification tool (see Appendix 3), while each patient's vulnerability to developing pressure ulcers was assessed using the Braden Scale. While the Braden Scale allows assessment of skin moisture it does not specifically address continence, and the EPUAP working group also included the continence section of the Norton scale within the data collection instrument. No attempt was made to combine the Braden and continence scores into a single indicator of possible vulnerability to pressure ulcers.

On two selected wards within each hospital, two members of the research team independently inspected the skin of patients to establish the level of agreement between observers. Across all participating countries the level of agreement between observers was very high (for the Braden scale 0.985, for the most severe pressure ulcer 0.963, and for the location with the most severe grade of pressure ulcer 0.934 all of these were significant at a p value of < 0.001). All completed forms were copied with the original data sheets returned to a central point for data processing and analysis.


Results

A total of 5947 patients were surveyed across the five countries, of these 1078 (18.1%) had established pressure ulcers. Patients were surveyed across twenty-six hospital sites with 48.2% (n = 2868) of all patients nursed within teaching hospitals, the remainder within general hospitals (Table 1). Of the 5947 patients surveyed, 2544 (42.8%) were located in the United Kingdom (drawn from eleven hospitals in England, two in Wales and two in Northern Ireland).

a) Patient demographic information.

The age of the surveyed patients was collected as a series of age ranges (for example whether the patient was aged between 80 and 89 years) and as such it is not possible to calculate the mean age of the surveyed population. Table 2 highlights the age distribution of the surveyed patients with 2921 (49.1%) aged over 70 years old. The age of 42 (0.7%) subjects was unreported. The mode age range varied by country, for example in Belgium most patients surveyed were between 40 and 49 years old, with over 12% under 18 years old. Across the other four countries patients tended to be older; mode age range 70-79 years (Italy and Portugal) and 80 to 89 years in Sweden and the United Kingdom. Most patients were female (n = 3088, 52.9%) with the sex of 109 (1.8%) unreported. The percentage of each country's surveyed patients where gender was unreported ranged from 0.9% (Portugal) to 3.6% (Italy). It is important to note that the demographic information presented in this section of the report includes all surveyed patients and not just those with pressure ulcers.

___________________________________________________________________________________________________________________
 
University
Hospital
Patients
Range of patients
per centre
General
Hospital
Patients
Range of patients
per centre
Portugal
-
-
-
3
786
158-441
Belgium
1
665
665
1
206
206
UK
4
820
22 - 567
11
1724
32 - 347
Sweden
2
613
24 - 589
1
36
36
Italy
2
770
243 - 527
1
327
327
Total
9
2868
17
3079
___________________________________________________________________________________________________________________

Above:
Table 1
The number of patients and the number of participating hospitals reported across the five countries that participated within the pilot prevalence survey.


__________________________________________________________________________________________
Number (percentage) of patients within each age group

 
Under 12 yrs
12-18 yrs
19-39 yrs
40-59 yrs
60-69 yrs
70-79 yrs
80-89 yrs
>89 yrs
Portugal
28 (3.6)
9 (1.1)
83 (10.6)
175 (22.3)
165 (21.0)
217 (27.7)
89 (11.4)
18 (2.3)
Belgium
77 (8.9)
19 (2.2)
109 (12.6)
201 (23.2)
155 (17.9)
160 (18.4)
112 (12.9)
35 (4.0)
UK
1 (0)
19 (0.8)
268 (10.6)
400 (15.8)
402 (15.9)
618 (24.4)
628 (24.8)
197 (7.8)
Sweden
3 (0.5)
50 (7.8)
152 (23.6)
104 (16.1)
129 (20.0)
167 (25.9)
39 (6.1)
Italy
42 (3.9)
11 (1.0)
93 (8.6)
187 (17.4)
231 (21.5)
295 (27.4)
176 (16.4)
41 (3.8)
Total
148 (2.5)
61 (1.0)
603 (10.2)
1115 (18.9)
1057 (17.9)
1419 (24.0)
1172 (19.8)
330 (5.6)
__________________________________________________________________________________________

Above: Table 2 The age of patients surveyed by country.

___________________________________________________________________________________________________________________
Country
Number of male patients
Number of female patients

Belgium
406
445
Italy
556
502
Portugal
417
362
Sweden
312
321
United Kingdom
1059
1458
Total
2750
3088
___________________________________________________________________________________________________________________

Above: Table 3 Distribution of male and female patients by country.


There are many different descriptions for the various medical specialities across Europe and in an attempt to make definition consistent across all countries that might use the EPUAP prevalence data collection instrument, generic categories covering medical speciality were constructed. For example 'acute care/high dependency' would include many surgical wards while 'chronic care' would include long term care of the elderly for example. Based upon these definitions, most of the patients were considered to be acute care/high dependency patients (n = 3703, 63.0%), Table 4. Only in Portugal did the mode care group differ with most patients surveyed considered to receive chronic care. Despite the unfamiliarity of these definitions the care group was unreported in only 68 (1.1%) cases.

b) Vulnerability to pressure ulcer development.

The vulnerability of each patient to developing pressure ulcers was assessed using the Braden Scale, this tool similar in structure to the Norton and Waterlow scales, provides a summary score based upon six patient characteristics - their ability to respond to sensory stimuli, the moistness of their skin, their activity, mobility and exposure to shear forces and finally their nutritional intake. A Braden Score of 16 or below is typically considered to mark a need for preventive interventions to be undertaken to prevent pressure ulcer development.

___________________________________________________________________________________________________________________


Country

Neurology

Intensive

Chronic Care

Acute Care/
High Dependency

Portugal
145 (18.5)
65 (8.3)
304 (38.8)
270 (34.4)
Belgium
149 (17.3)
74 (8.6)
209 (24.3)
427 (49.7)
UK
375 (14.8)
43 (1.7)
456 (18.0)
1653 (65.4)
Sweden
35 (5.5)
32 (5.0)
84 (13.2)
487 (76.3)
Italy
125 (11.7)
55 (5.1)
25 (2.3)
866 (80.9)
Total
829 (14.1)
269 (4.6)
1078 (18.3)
3703 (63.0)
___________________________________________________________________________________________________________________

Above:
Table 4.
Location of the patients in each surveyed country by medical care group.

___________________________________________________________________________________________________________________


Country

Not at risk
% not at risk
(Braden score 17+)
At Risk (Braden
score 16 or lower)


% at risk

Belgium
562
65.1
301
34.9
Italy
783
77.4
229
22.6
Portugal
551
70.5
231
29.5
Sweden
468
76.2
146
23.8
UK
1663
66.8
826
33.2
Total
4027
69.9
1733
30.1
___________________________________________________________________________________________________________________

Above:
Table 5.
Vulnerability to developing pressure ulcers by country. Percentages based upon the total number of patients with reported Braden scores (n = 5760).


Typically the Braden Scores recorded for the patients surveyed across the participating European countries ranged from 6 to 23, median score 19. The three exceptions to this were; the minimum Braden scores recorded in Portugal and Sweden were 7 and 9 respectively, while the median Braden score recorded in Italy was 21. Based on their Braden Scores, 1733 (29.1%) of all surveyed patients were at risk of developing pressure damage (Table 5). The percentage of patients considered at risk of developing pressure ulcers was highest in Belgium (34.9%) and the United Kingdom (33.2%). The Braden Scores of 187 patients were unreported during the surveys. Most unreported Braden scores occurred among the surveyed Italian patients (n = 85, 7.7%), with the most complete risk assessment data derived in Portugal (missing data n = 4, 0.5%).

Use of the Braden Scale was supplemented by the capture of specific information upon each patient's level of continence using the continence section of the Norton scale. This section offers four possible responses scored from 1 (fully continent) to 4 (doubly incontinent). While inclusion of the continence section of the Norton scale offers more information that may pertain to the current risk of a patient developing pressure ulcers it may be difficult to complete given a lack of operational definitions - for example how should an incontinent but catheterised patient be scored? Regardless of these issues, most patients were assessed as being continent (n = 4417, 75.1%), Table 6. Most doubly incontinent patients were found among the Belgian (16.4%) and UK (10.7%) surveyed patients. The continence status of 69 (1.2%) patients was unreported with 38 missing cases within the Italian survey (3.5% of all patients surveyed in Italy).

___________________________________________________________________________________________________________________


Country

Continent
Occasional
incontinence
Urinary
incontinence
Double
incontinence

Belgium
577 (66.3)
110 (12.6)
40 (4.6)
143 (16.4)
Italy
920 (86.9)
69 (6.5)
38 (3.6)
32 (3.0)
Portugal
601 (76.8)
102 (13.0)
21 (2.7)
59 (7.5)
Sweden
512 (79.6)
60 (9.3)
33 (5.1)
38 (5.9)
UK
1807 (71.6)
353 (14.0)
93 (3.7)
270 (10.7)
Total
4417 (75.1)
694 (11.8)
225 (3.8)
542 (9.2)
___________________________________________________________________________________________________________________

Above:
Table 6.
Reported continence of the surveyed patients by country. Data shows both the absolute numbers of patients and the percentage, shown in parenthesis, within each category.

 
Review Contents Return to Top Next Page

© European Pressure Ulcer Advisory Panel
Contact Us

Created by eDoodle group